Harvard Perspectives on Prostate Disease

Advances and breakthroughs in prostate disease

Reviewed by Per-Anders Abrahamsson, M.D., Ph.D.

Advances in the understanding and treatment of prostate disease are constantly being reported at scientific meetings and in peer-reviewed publications. What follows are some of the most interesting recent findings, placed in context by Per-Anders Abrahamsson, M.D., Ph.D., a member of Perspectives' editorial and advisory board, and Secretary General of the European Association of Urology, the leading professional organization overseas.

Multivitamins and prostate cancer: A new worry?

To explore the link between multivitamins and prostate cancer, scientists at the National Cancer Institute studied 295,344 men who participated in the National Institutes of Health""AARP Diet and Health Study. At the start of the study, the men were between the ages of 50 and 71 and free of cancer. After five years of follow-up, scientists found no link between multivitamin use and the risk of developing localized prostate cancer. But compared with men who did not take multivitamins, men who took them more than seven times a week were 32% more likely to develop advanced prostate cancer and 98% more likely to die from the disease.

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »